February 20, 2020
In Episode 2 of the U.S. Hemp Roundtable’s new podcast, Hemp Table Talk, The Roundtable’s General Counsel, Jonathan Miller, and the FDA Counsel, Rend Al-Mondhiry, discuss the current state of the FDA's perspective on CBD and CBD-based products. During the podcast, they interview Front Range Biosciences' CEO and Co-Founder, Dr. Jonathan Vaught, to learn about his experience testifying at the FDA's public hearing on cannabis-derived compounds in May 2019. Dr. Vaught explains how developing a regulatory framework would provide clarity for companies aiming to produce products containing CBD as a dietary supplement or food additive.
Listen to the full podcast to learn more.
Please complete the contact form below to receive our farming recommendations.